Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ga Hee Kim

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Gastrointestinal Endoscopy|October 27, 2019
Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case-control studyGa Hee Kim, Kee Don Choi, Chung Sik Gong, et al.
Journal of Neurogastroenterology and Motility|October 14, 2024
Optimal Diagnostic and Treatment Response Threshold of the Eosinophilic Esophagitis Endoscopic Reference Score: A Single-Center Study of 102 Patients With Eosinophilic EsophagitisKwangbeom Park, Bokyung Ahn, Kee Wook Jung, et al.
Cancers|July 24, 2021
Impact of Comorbidities, Sarcopenia, and Nutritional Status on the Long-Term Outcomes after Endoscopic Submucosal Dissection for Early Gastric Cancer in Elderly Patients Aged ≥ 80 YearsGa Hee Kim, Kee Don Choi, Yousun Ko, et al.
Gut and Liver|May 25, 2022
Clinical Significance of Epstein-Barr Virus and <i>Helicobacter pylori</i> Infection in Gastric CarcinomaJin Hee Noh, Jun Young Shin, Jeong Hoon Lee, et al.
Drug Delivery|June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancerGa Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports|December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyHee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Journal of Neurogastroenterology and Motility|July 8, 2025
Validation of Lyon 2.0 Gastroesophageal Reflux Disease Consensus: Limited Clinical Utility of Mean Nocturnal Basal Impedance in KoreansJae Hyuk Lee, Boram Cha, Kee Wook Jung, et al.
World Journal of Gastroenterology|May 18, 2022
Reevaluation of the expanded indications in undifferentiated early gastric cancer for endoscopic submucosal dissectionJiyoung Yoon, Seung-Yeon Yoo, Young Soo Park, et al.
Journal of Gastroenterology and Hepatology|December 2, 2017
Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancerCharles J Cho, Hyo Jeong Kang, Se Jeong Park, et al.
Cancer Research|August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian CancerYeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Gastrointestinal Endoscopy|October 27, 2019
Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case-control studyGa Hee Kim, Kee Don Choi, Chung Sik Gong, et al.
Journal of Neurogastroenterology and Motility|October 14, 2024
Optimal Diagnostic and Treatment Response Threshold of the Eosinophilic Esophagitis Endoscopic Reference Score: A Single-Center Study of 102 Patients With Eosinophilic EsophagitisKwangbeom Park, Bokyung Ahn, Kee Wook Jung, et al.
Cancers|July 24, 2021
Impact of Comorbidities, Sarcopenia, and Nutritional Status on the Long-Term Outcomes after Endoscopic Submucosal Dissection for Early Gastric Cancer in Elderly Patients Aged ≥ 80 YearsGa Hee Kim, Kee Don Choi, Yousun Ko, et al.
Gut and Liver|May 25, 2022
Clinical Significance of Epstein-Barr Virus and <i>Helicobacter pylori</i> Infection in Gastric CarcinomaJin Hee Noh, Jun Young Shin, Jeong Hoon Lee, et al.
Drug Delivery|June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancerGa Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports|December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapyHee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Journal of Neurogastroenterology and Motility|July 8, 2025
Validation of Lyon 2.0 Gastroesophageal Reflux Disease Consensus: Limited Clinical Utility of Mean Nocturnal Basal Impedance in KoreansJae Hyuk Lee, Boram Cha, Kee Wook Jung, et al.
World Journal of Gastroenterology|May 18, 2022
Reevaluation of the expanded indications in undifferentiated early gastric cancer for endoscopic submucosal dissectionJiyoung Yoon, Seung-Yeon Yoo, Young Soo Park, et al.
Journal of Gastroenterology and Hepatology|December 2, 2017
Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancerCharles J Cho, Hyo Jeong Kang, Se Jeong Park, et al.
Cancer Research|August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian CancerYeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Pageof 9